# NCI Diversity Supplement: Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants

> **NIH NIH R01** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2024 · $69,324

## Abstract

ABSTRACT
A separate Abstract is not requested.
This is an NCI Diversity Supplement to Dr. Juan Fueyo-Margareto’s NCI grant, R01 CA256006,
titled, “Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants.”

## Key facts

- **NIH application ID:** 10993440
- **Project number:** 3R01CA256006-04S1
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Juan Fueyo
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $69,324
- **Award type:** 3
- **Project period:** 2021-02-01 → 2026-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10993440

## Citation

> US National Institutes of Health, RePORTER application 10993440, NCI Diversity Supplement: Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants (3R01CA256006-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10993440. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*